Penicillin Active Pharmaceutical Ingredients Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Publisher Name :
Date: 30-Apr-2020
No. of pages: 101

Penicillin refers to a class of antibiotics containing penicillin in the molecule, which can destroy the cell wall of bacteria and play a bactericidal role in the breeding period of bacterial cells. The active pharmaceutical ingredient (API) is the part of any drug that produces the intended effects.

This report contains market size and forecasts of Penicillin Active Pharmaceutical Ingredients in US, including the following market information:

US Penicillin Active Pharmaceutical Ingredients Market Revenue, 2015-2020, 2021-2026, ($ millions)

US Penicillin Active Pharmaceutical Ingredients Market Consumption, 2015-2020, 2021-2026, (MT)

US Penicillin Active Pharmaceutical Ingredients Production Capacity, 2015-2020, 2021-2026, (MT)

Top Five Competitors in US Penicillin Active Pharmaceutical Ingredients Market 2019 (%)

The global Penicillin Active Pharmaceutical Ingredients market was valued at 2515.9 million in 2019 and is projected to reach US$ 2965 million by 2026, at a CAGR of 4.2% during the forecast period. While the Penicillin Active Pharmaceutical Ingredients market size in US was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Penicillin Active Pharmaceutical Ingredients manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.

This report also analyses and evaluates the COVID-19 impact on Penicillin Active Pharmaceutical Ingredients production and consumption in US

Total Market by Segment:

US Penicillin Active Pharmaceutical Ingredients Market, By Type, 2015-2020, 2021-2026 ($ millions) & (MT)

US Penicillin Active Pharmaceutical Ingredients Market Segment Percentages, By Type, 2019 (%)

- Penicillin G Potassium

- Ampicillin

- Piperacillin

- Sulbactam Sodium

- Tazobactam

- Clavulanic Acid

- Amoxicillin

- The proportion of penicillin G potassium in 2019 is about 64.85%.

US Penicillin Active Pharmaceutical Ingredients Market, By Application, 2015-2020, 2021-2026 ($ millions) & (MT)

US Penicillin Active Pharmaceutical Ingredients Market Segment Percentages, By Application, 2019 (%)

- For Oral

- For Injection

- Penicillin active pharmaceutical ingredients is widely for oral and injection. The proportion of oral in 2019 is about 62.70%.

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Penicillin Active Pharmaceutical Ingredients Market Competitors Revenues in US, by Players 2015-2020 (Estimated), ($ millions)

Total Penicillin Active Pharmaceutical Ingredients Market Competitors Revenues Share in US, by Players 2019 (%)

Total US Penicillin Active Pharmaceutical Ingredients Market Competitors Sales, by Players 2015-2020 (Estimated), (MT)

Total US Penicillin Active Pharmaceutical Ingredients Market Competitors Sales Market Share by Players 2019 ($ millions)

Further, the report presents profiles of competitors in the market, including the following:

- Centrient Pharmaceuticals

- Jiangxi Fushine Pharmaceutical

- Kelun

- Harbin Pharmaceutical Group

- Changzhou RedSun

- Jiangxi Huabang

- LKPC

- Huaxing Pharma

- North China Pharmaceutical

- Qilu Tianhe Pharma

- Novartis (Sandoz Anti-Infectives)

- CSPC Zhongrun

- United Laboratories

Penicillin Active Pharmaceutical Ingredients Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Penicillin Active Pharmaceutical Ingredients Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 US Penicillin Active Pharmaceutical Ingredients Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

2 COVID-19 Impact: US Penicillin Active Pharmaceutical Ingredients Overall Market Size
2.1 US Penicillin Active Pharmaceutical Ingredients Market Size: 2020 VS 2026
2.2 US Penicillin Active Pharmaceutical Ingredients Revenue, Prospects & Forecasts: 2015-2026
2.3 US Penicillin Active Pharmaceutical Ingredients Sales (Consumption): 2015-2026

3 Company Landscape
3.1 Top Penicillin Active Pharmaceutical Ingredients Players in US (including Foreign and Local Companies)
3.2 Top US Penicillin Active Pharmaceutical Ingredients Companies Ranked by Revenue
3.3 US Penicillin Active Pharmaceutical Ingredients Revenue by Companies (including Foreign and Local Companies)
3.4 US Penicillin Active Pharmaceutical Ingredients Sales by Companies (including Foreign and Local Companies)
3.5 US Penicillin Active Pharmaceutical Ingredients Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Penicillin Active Pharmaceutical Ingredients Companies in US, by Revenue in 2019
3.7 US Manufacturers Penicillin Active Pharmaceutical Ingredients Product Type
3.8 Tier 1, Tier 2 and Tier 3 Penicillin Active Pharmaceutical Ingredients Players in US
3.8.1 List of US Tier 1 Penicillin Active Pharmaceutical Ingredients Companies
3.8.2 List of US Tier 2 and Tier 3 Penicillin Active Pharmaceutical Ingredients Companies

4 Sights by Product
4.1 Overview
4.1.1 By Type - US Penicillin Active Pharmaceutical Ingredients Market Size Markets, 2020 & 2026
4.1.2 Penicillin G Potassium
4.1.3 Ampicillin
4.1.4 Piperacillin
4.1.5 Sulbactam Sodium
4.1.6 Tazobactam
4.1.7 Clavulanic Acid
4.1.8 Amoxicillin
4.2 By Type - US Penicillin Active Pharmaceutical Ingredients Revenue & Forecasts
4.2.1 By Type - US Penicillin Active Pharmaceutical Ingredients Revenue, 2015-2020
4.2.2 By Type - US Penicillin Active Pharmaceutical Ingredients Revenue, 2021-2026
4.2.3 By Type - US Penicillin Active Pharmaceutical Ingredients Revenue Market Share, 2015-2026
4.3 By Type - US Penicillin Active Pharmaceutical Ingredients Sales & Forecasts
4.3.1 By Type - US Penicillin Active Pharmaceutical Ingredients Sales, 2015-2020
4.3.2 By Type - US Penicillin Active Pharmaceutical Ingredients Sales, 2021-2026
4.3.3 By Type - US Penicillin Active Pharmaceutical Ingredients Sales Market Share, 2015-2026
4.4 By Type - US Penicillin Active Pharmaceutical Ingredients Price (Manufacturers Selling Prices), 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - US Penicillin Active Pharmaceutical Ingredients Market Size, 2020 & 2026
5.1.2 For Oral
5.1.3 For Injection
5.2 By Application - US Penicillin Active Pharmaceutical Ingredients Revenue & Forecasts
5.2.1 By Application - US Penicillin Active Pharmaceutical Ingredients Revenue, 2015-2020
5.2.2 By Application - US Penicillin Active Pharmaceutical Ingredients Revenue, 2021-2026
5.2.3 By Application - US Penicillin Active Pharmaceutical Ingredients Revenue Market Share, 2015-2026
5.3 By Application - US Penicillin Active Pharmaceutical Ingredients Sales & Forecasts
5.3.1 By Application - US Penicillin Active Pharmaceutical Ingredients Sales, 2015-2020
5.3.2 By Application - US Penicillin Active Pharmaceutical Ingredients Sales, 2021-2026
5.3.3 By Application - US Penicillin Active Pharmaceutical Ingredients Sales Market Share, 2015-2026
5.4 By Application - US Penicillin Active Pharmaceutical Ingredients Price (Manufacturers Selling Prices), 2015-2026
6 Manufacturers & Brands Profiles
6.1 Centrient Pharmaceuticals
6.1.1 Centrient Pharmaceuticals Corporate Summary
6.1.2 Centrient Pharmaceuticals Business Overview
6.1.3 Centrient Pharmaceuticals Penicillin Active Pharmaceutical Ingredients Major Product Offerings
6.1.4 Centrient Pharmaceuticals Sales and Revenue in US (2015-2020)
6.1.5 Centrient Pharmaceuticals Key News
6.2 Jiangxi Fushine Pharmaceutical
6.2.1 Jiangxi Fushine Pharmaceutical Corporate Summary
6.2.2 Jiangxi Fushine Pharmaceutical Business Overview
6.2.3 Jiangxi Fushine Pharmaceutical Penicillin Active Pharmaceutical Ingredients Major Product Offerings
6.2.4 Jiangxi Fushine Pharmaceutical Sales and Revenue in US (2015-2020)
6.2.5 Jiangxi Fushine Pharmaceutical Key News
6.3 Kelun
6.3.1 Kelun Corporate Summary
6.3.2 Kelun Business Overview
6.3.3 Kelun Penicillin Active Pharmaceutical Ingredients Major Product Offerings
6.3.4 Kelun Sales and Revenue in US (2015-2020)
6.3.5 Kelun Key News
6.4 Harbin Pharmaceutical Group
6.4.1 Harbin Pharmaceutical Group Corporate Summary
6.4.2 Harbin Pharmaceutical Group Business Overview
6.4.3 Harbin Pharmaceutical Group Penicillin Active Pharmaceutical Ingredients Major Product Offerings
6.4.4 Harbin Pharmaceutical Group Sales and Revenue in US (2015-2020)
6.4.5 Harbin Pharmaceutical Group Key News
6.5 Changzhou RedSun
6.5.1 Changzhou RedSun Corporate Summary
6.5.2 Changzhou RedSun Business Overview
6.5.3 Changzhou RedSun Penicillin Active Pharmaceutical Ingredients Major Product Offerings
6.5.4 Changzhou RedSun Sales and Revenue in US (2015-2020)
6.5.5 Changzhou RedSun Key News
6.6 Jiangxi Huabang
6.6.1 Jiangxi Huabang Corporate Summary
6.6.2 Jiangxi Huabang Business Overview
6.6.3 Jiangxi Huabang Penicillin Active Pharmaceutical Ingredients Major Product Offerings
6.6.4 Jiangxi Huabang Sales and Revenue in US (2015-2020)
6.6.5 Jiangxi Huabang Key News
6.7 LKPC
6.6.1 LKPC Corporate Summary
6.6.2 LKPC Business Overview
6.6.3 LKPC Penicillin Active Pharmaceutical Ingredients Major Product Offerings
6.4.4 LKPC Sales and Revenue in US (2015-2020)
6.7.5 LKPC Key News
6.8 Huaxing Pharma
6.8.1 Huaxing Pharma Corporate Summary
6.8.2 Huaxing Pharma Business Overview
6.8.3 Huaxing Pharma Penicillin Active Pharmaceutical Ingredients Major Product Offerings
6.8.4 Huaxing Pharma Sales and Revenue in US (2015-2020)
6.8.5 Huaxing Pharma Key News
6.9 North China Pharmaceutical
6.9.1 North China Pharmaceutical Corporate Summary
6.9.2 North China Pharmaceutical Business Overview
6.9.3 North China Pharmaceutical Penicillin Active Pharmaceutical Ingredients Major Product Offerings
6.9.4 North China Pharmaceutical Sales and Revenue in US (2015-2020)
6.9.5 North China Pharmaceutical Key News
6.10 Qilu Tianhe Pharma
6.10.1 Qilu Tianhe Pharma Corporate Summary
6.10.2 Qilu Tianhe Pharma Business Overview
6.10.3 Qilu Tianhe Pharma Penicillin Active Pharmaceutical Ingredients Major Product Offerings
6.10.4 Qilu Tianhe Pharma Sales and Revenue in US (2015-2020)
6.10.5 Qilu Tianhe Pharma Key News
6.11 Novartis (Sandoz Anti-Infectives)
6.11.1 Novartis (Sandoz Anti-Infectives) Corporate Summary
6.11.2 Novartis (Sandoz Anti-Infectives) Penicillin Active Pharmaceutical Ingredients Business Overview
6.11.3 Novartis (Sandoz Anti-Infectives) Penicillin Active Pharmaceutical Ingredients Major Product Offerings
6.11.4 Novartis (Sandoz Anti-Infectives) Sales and Revenue in US (2015-2020)
6.11.5 Novartis (Sandoz Anti-Infectives) Key News
6.12 CSPC Zhongrun
6.12.1 CSPC Zhongrun Corporate Summary
6.12.2 CSPC Zhongrun Penicillin Active Pharmaceutical Ingredients Business Overview
6.12.3 CSPC Zhongrun Penicillin Active Pharmaceutical Ingredients Major Product Offerings
6.12.4 CSPC Zhongrun Sales and Revenue in US (2015-2020)
6.12.5 CSPC Zhongrun Key News
6.13 United Laboratories
6.13.1 United Laboratories Corporate Summary
6.13.2 United Laboratories Penicillin Active Pharmaceutical Ingredients Business Overview
6.13.3 United Laboratories Penicillin Active Pharmaceutical Ingredients Major Product Offerings
6.13.4 United Laboratories Sales and Revenue in US (2015-2020)
6.13.5 United Laboratories Key News
6.14 Sinopharm Weiqida Pharmaceutical
6.14.1 Sinopharm Weiqida Pharmaceutical Corporate Summary
6.14.2 Sinopharm Weiqida Pharmaceutical Penicillin Active Pharmaceutical Ingredients Business Overview
6.14.3 Sinopharm Weiqida Pharmaceutical Penicillin Active Pharmaceutical Ingredients Major Product Offerings
6.14.4 Sinopharm Weiqida Pharmaceutical Sales and Revenue in US (2015-2020)
6.14.5 Sinopharm Weiqida Pharmaceutical Key News

7 Penicillin Active Pharmaceutical Ingredients Production Capacity, Export and Import Analysis
7.1 Penicillin Active Pharmaceutical Ingredients Production Capacity and Value in US, Situation Analysis and Prediction, 2015-2026
7.1.1 US Penicillin Active Pharmaceutical Ingredients Production Capacity, 2015-2026
7.1.2 US Penicillin Active Pharmaceutical Ingredients Production 2015-2026
7.1.3 US Penicillin Active Pharmaceutical Ingredients Production Value 2015-2026
7.2 Key Local Penicillin Active Pharmaceutical Ingredients Manufacturers in US
7.2.1 US Key Local Penicillin Active Pharmaceutical Ingredients Manufacturers Production Capacity
7.2.2 US Key Local Penicillin Active Pharmaceutical Ingredients Manufacturers Production
7.2.3 US Key Local Penicillin Active Pharmaceutical Ingredients Manufacturers Production Value
7.2.4 The Proportion of Penicillin Active Pharmaceutical Ingredients Production Sold in US and Sold Other Than US by Manufacturers
7.3 Penicillin Active Pharmaceutical Ingredients Export and Import in US
7.3.1 US Penicillin Active Pharmaceutical Ingredients Export Market
7.3.2 US Penicillin Active Pharmaceutical Ingredients Source of Imports

8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints
8.1 PESTLE Analysis for US Penicillin Active Pharmaceutical Ingredients Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 Impact on Penicillin Active Pharmaceutical Ingredients Supply Chain Analysis
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Penicillin Active Pharmaceutical Ingredients Distributors and Sales Agents in US

10 Conclusion

11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer

List of Tables
Table 1. Key Players of Penicillin Active Pharmaceutical Ingredients in US
Table 2. Top Players in US, Ranking by Revenue (2019)
Table 3. US Penicillin Active Pharmaceutical Ingredients Revenue by Companies, (US$, Mn), 2015-2020
Table 4. US Penicillin Active Pharmaceutical Ingredients Revenue Share by Companies, 2015-2020
Table 5. US Penicillin Active Pharmaceutical Ingredients Sales by Companies, (MT), 2015-2020
Table 6. US Penicillin Active Pharmaceutical Ingredients Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Penicillin Active Pharmaceutical Ingredients Price (2015-2020) (USD/Kg)
Table 8. US Manufacturers Penicillin Active Pharmaceutical Ingredients Product Type
Table 9. List of US Tier 1 Penicillin Active Pharmaceutical Ingredients Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of US Tier 2 and Tier 3 Penicillin Active Pharmaceutical Ingredients Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Penicillin Active Pharmaceutical Ingredients Revenue in US (US$, Mn), 2015-2020
Table 12. By Type - Penicillin Active Pharmaceutical Ingredients Revenue in US (US$, Mn), 2021-2026
Table 13. By Type - Penicillin Active Pharmaceutical Ingredients Sales in US (MT), 2015-2020
Table 14. By Type - Penicillin Active Pharmaceutical Ingredients Sales in US (MT), 2021-2026
Table 15. By Application - Penicillin Active Pharmaceutical Ingredients Revenue in US, (US$, Mn), 2015-2020
Table 16. By Application - Penicillin Active Pharmaceutical Ingredients Revenue in US, (US$, Mn), 2021-2026
Table 17. By Application - Penicillin Active Pharmaceutical Ingredients Sales in US, (MT), 2015-2020
Table 18. By Application - Penicillin Active Pharmaceutical Ingredients Sales in US, (MT), 2021-2026
Table 19. Centrient Pharmaceuticals Corporate Summary
Table 20. Centrient Pharmaceuticals Penicillin Active Pharmaceutical Ingredients Product Offerings
Table 21. Centrient Pharmaceuticals Penicillin Active Pharmaceutical Ingredients Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 22. Jiangxi Fushine Pharmaceutical Corporate Summary
Table 23. Jiangxi Fushine Pharmaceutical Penicillin Active Pharmaceutical Ingredients Product Offerings
Table 24. Jiangxi Fushine Pharmaceutical Penicillin Active Pharmaceutical Ingredients Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 25. Kelun Corporate Summary
Table 26. Kelun Penicillin Active Pharmaceutical Ingredients Product Offerings
Table 27. Kelun Penicillin Active Pharmaceutical Ingredients Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 28. Harbin Pharmaceutical Group Corporate Summary
Table 29. Harbin Pharmaceutical Group Penicillin Active Pharmaceutical Ingredients Product Offerings
Table 30. Harbin Pharmaceutical Group Penicillin Active Pharmaceutical Ingredients Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 31. Changzhou RedSun Corporate Summary
Table 32. Changzhou RedSun Penicillin Active Pharmaceutical Ingredients Product Offerings
Table 33. Changzhou RedSun Penicillin Active Pharmaceutical Ingredients Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 34. Jiangxi Huabang Corporate Summary
Table 35. Jiangxi Huabang Penicillin Active Pharmaceutical Ingredients Product Offerings
Table 36. Jiangxi Huabang Penicillin Active Pharmaceutical Ingredients Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 37. LKPC Corporate Summary
Table 38. LKPC Penicillin Active Pharmaceutical Ingredients Product Offerings
Table 39. LKPC Penicillin Active Pharmaceutical Ingredients Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 40. Huaxing Pharma Corporate Summary
Table 41. Huaxing Pharma Penicillin Active Pharmaceutical Ingredients Product Offerings
Table 42. Huaxing Pharma Penicillin Active Pharmaceutical Ingredients Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 43. North China Pharmaceutical Corporate Summary
Table 44. North China Pharmaceutical Penicillin Active Pharmaceutical Ingredients Product Offerings
Table 45. North China Pharmaceutical Penicillin Active Pharmaceutical Ingredients Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 46. Qilu Tianhe Pharma Corporate Summary
Table 47. Qilu Tianhe Pharma Penicillin Active Pharmaceutical Ingredients Product Offerings
Table 48. Qilu Tianhe Pharma Penicillin Active Pharmaceutical Ingredients Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 49. Novartis (Sandoz Anti-Infectives) Corporate Summary
Table 50. Novartis (Sandoz Anti-Infectives) Penicillin Active Pharmaceutical Ingredients Product Offerings
Table 51. Novartis (Sandoz Anti-Infectives) Penicillin Active Pharmaceutical Ingredients Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 52. CSPC Zhongrun Corporate Summary
Table 53. CSPC Zhongrun Penicillin Active Pharmaceutical Ingredients Product Offerings
Table 54. CSPC Zhongrun Penicillin Active Pharmaceutical Ingredients Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 55. United Laboratories Corporate Summary
Table 56. United Laboratories Penicillin Active Pharmaceutical Ingredients Product Offerings
Table 57. United Laboratories Penicillin Active Pharmaceutical Ingredients Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 58. Sinopharm Weiqida Pharmaceutical Corporate Summary
Table 59. Sinopharm Weiqida Pharmaceutical Penicillin Active Pharmaceutical Ingredients Product Offerings
Table 60. Sinopharm Weiqida Pharmaceutical Penicillin Active Pharmaceutical Ingredients Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 61. Penicillin Active Pharmaceutical Ingredients Production Capacity (MT) of Local Manufacturers in US, 2015-2020
Table 62. Penicillin Active Pharmaceutical Ingredients Production (MT) of Local Manufacturers in US, 2015-2020
Table 63. US Penicillin Active Pharmaceutical Ingredients Production Market Share of Local Manufacturers, 2015-2020
Table 64. Penicillin Active Pharmaceutical Ingredients Production Value (US$, Mn) of Local Manufacturers in US, 2015-2020
Table 65. US Penicillin Active Pharmaceutical Ingredients Production Value Market Share of Local Manufacturers, 2015-2020
Table 66. The Percentage of Penicillin Active Pharmaceutical Ingredients Production Sold in US and Sold Other Than US by Manufacturers
Table 67. The Percentage of Penicillin Active Pharmaceutical Ingredients Production Sold in US and Sold Other Than US by Manufacturers
Table 68. Dangeguojia Penicillin Active Pharmaceutical Ingredients Sales (Consumption), Production, Export and Import, 2015-2020
Table 69. Raw Materials and Suppliers
Table 70. Penicillin Active Pharmaceutical Ingredients Downstream Clients in US
Table 71. Penicillin Active Pharmaceutical Ingredients Distributors and Sales Agents in US
List of Figures
Figure 1. Penicillin Active Pharmaceutical Ingredients Segment by Type
Figure 2. Penicillin Active Pharmaceutical Ingredients Segment by Application
Figure 3. Dangeguojia Penicillin Active Pharmaceutical Ingredients Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Penicillin Active Pharmaceutical Ingredients Market Size in US, (US$, Mn) & (MT): 2020 VS 2026
Figure 6. US Penicillin Active Pharmaceutical Ingredients Revenue, 2015-2026 (US$, Mn)
Figure 7. Penicillin Active Pharmaceutical Ingredients Sales in US: 2015-2026 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Penicillin Active Pharmaceutical Ingredients Revenue in 2019
Figure 9. By Type - US Penicillin Active Pharmaceutical Ingredients Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - US Penicillin Active Pharmaceutical Ingredients Market Share, 2015-2020
Figure 11. By Type - US Penicillin Active Pharmaceutical Ingredients Market Share, 2020-2026
Figure 12. By Type - US Penicillin Active Pharmaceutical Ingredients Price (USD/Kg), 2015-2026
Figure 13. By Application - Penicillin Active Pharmaceutical Ingredients Revenue in US (US$, Mn), 2020 & 2026
Figure 14. By Application - US Penicillin Active Pharmaceutical Ingredients Market Share, 2015-2020
Figure 15. By Application - US Penicillin Active Pharmaceutical Ingredients Market Share, 2020-2026
Figure 16. By Application -US Penicillin Active Pharmaceutical Ingredients Price (USD/Kg), 2015-2026
Figure 17. US Penicillin Active Pharmaceutical Ingredients Production Capacity (MT), 2015-2026
Figure 18. US Penicillin Active Pharmaceutical Ingredients Actual Output (MT), 2015-2026
Figure 19. US Penicillin Active Pharmaceutical Ingredients Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of US Penicillin Active Pharmaceutical Ingredients Export Destination, 2019
Figure 21. The Source of Imports of US Penicillin Active Pharmaceutical Ingredients, 2019
Figure 22. PEST Analysis for US Penicillin Active Pharmaceutical Ingredients Market in 2020
Figure 23. Penicillin Active Pharmaceutical Ingredients Market Opportunities & Trends in US
Figure 24. Penicillin Active Pharmaceutical Ingredients Market Drivers in US
Figure 25. Penicillin Active Pharmaceutical Ingredients Market Restraints in US
Figure 26. Penicillin Active Pharmaceutical Ingredients Industry Value Chain
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs